These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 18096515)
1. Low temperature induces the delivery of mature and immature CFTR to the plasma membrane. Rennolds J; Boyaka PN; Bellis SL; Cormet-Boyaka E Biochem Biophys Res Commun; 2008 Feb; 366(4):1025-9. PubMed ID: 18096515 [TBL] [Abstract][Full Text] [Related]
2. Trafficking of immature DeltaF508-CFTR to the plasma membrane and its detection by biotinylation. Luo Y; McDonald K; Hanrahan JW Biochem J; 2009 Apr; 419(1):211-9, 2 p following 219. PubMed ID: 19053947 [TBL] [Abstract][Full Text] [Related]
3. Surface expression of the cystic fibrosis transmembrane conductance regulator mutant DeltaF508 is markedly upregulated by combination treatment with sodium butyrate and low temperature. Heda GD; Marino CR Biochem Biophys Res Commun; 2000 May; 271(3):659-64. PubMed ID: 10814518 [TBL] [Abstract][Full Text] [Related]
4. Rescue of DeltaF508-CFTR (cystic fibrosis transmembrane conductance regulator) by curcumin: involvement of the keratin 18 network. Lipecka J; Norez C; Bensalem N; Baudouin-Legros M; Planelles G; Becq F; Edelman A; Davezac N J Pharmacol Exp Ther; 2006 May; 317(2):500-5. PubMed ID: 16424149 [TBL] [Abstract][Full Text] [Related]
5. Base treatment corrects defects due to misfolding of mutant cystic fibrosis transmembrane conductance regulator. Namkung W; Kim KH; Lee MG Gastroenterology; 2005 Dec; 129(6):1979-90. PubMed ID: 16344066 [TBL] [Abstract][Full Text] [Related]
6. Misassembled mutant DeltaF508 CFTR in the distal secretory pathway alters cellular lipid trafficking. Gentzsch M; Choudhury A; Chang XB; Pagano RE; Riordan JR J Cell Sci; 2007 Feb; 120(Pt 3):447-55. PubMed ID: 17213331 [TBL] [Abstract][Full Text] [Related]
7. Dynasore inhibits removal of wild-type and DeltaF508 cystic fibrosis transmembrane conductance regulator (CFTR) from the plasma membrane. Young A; Gentzsch M; Abban CY; Jia Y; Meneses PI; Bridges RJ; Bradbury NA Biochem J; 2009 Jul; 421(3):377-85. PubMed ID: 19442237 [TBL] [Abstract][Full Text] [Related]
8. Rescue of ΔF508-CFTR trafficking via a GRASP-dependent unconventional secretion pathway. Gee HY; Noh SH; Tang BL; Kim KH; Lee MG Cell; 2011 Sep; 146(5):746-60. PubMed ID: 21884936 [TBL] [Abstract][Full Text] [Related]
10. Correctors enhance maturation of DeltaF508 CFTR by promoting interactions between the two halves of the molecule. Loo TW; Bartlett MC; Clarke DM Biochemistry; 2009 Oct; 48(41):9882-90. PubMed ID: 19761259 [TBL] [Abstract][Full Text] [Related]
12. Mild processing defect of porcine DeltaF508-CFTR suggests that DeltaF508 pigs may not develop cystic fibrosis disease. Liu Y; Wang Y; Jiang Y; Zhu N; Liang H; Xu L; Feng X; Yang H; Ma T Biochem Biophys Res Commun; 2008 Aug; 373(1):113-8. PubMed ID: 18555011 [TBL] [Abstract][Full Text] [Related]
13. S-nitrosylating agents: a novel class of compounds that increase cystic fibrosis transmembrane conductance regulator expression and maturation in epithelial cells. Zaman K; Carraro S; Doherty J; Henderson EM; Lendermon E; Liu L; Verghese G; Zigler M; Ross M; Park E; Palmer LA; Doctor A; Stamler JS; Gaston B Mol Pharmacol; 2006 Oct; 70(4):1435-42. PubMed ID: 16857740 [TBL] [Abstract][Full Text] [Related]
14. Rescue of DeltaF508 and other misprocessed CFTR mutants by a novel quinazoline compound. Loo TW; Bartlett MC; Clarke DM Mol Pharm; 2005; 2(5):407-13. PubMed ID: 16196493 [TBL] [Abstract][Full Text] [Related]
15. Identification of natural coumarin compounds that rescue defective DeltaF508-CFTR chloride channel gating. Xu LN; Na WL; Liu X; Hou SG; Lin S; Yang H; Ma TH Clin Exp Pharmacol Physiol; 2008 Aug; 35(8):878-83. PubMed ID: 18430055 [TBL] [Abstract][Full Text] [Related]
16. Correctors promote folding of the CFTR in the endoplasmic reticulum. Loo TW; Bartlett MC; Clarke DM Biochem J; 2008 Jul; 413(1):29-36. PubMed ID: 18361776 [TBL] [Abstract][Full Text] [Related]